Market Research Logo

Oman Pharmaceuticals and Healthcare Report Q2 2016

Oman Pharmaceuticals and Healthcare Report Q2 2016

BMI View: We uphold our view that Oman's pharmaceuticals and healthcare markets will remain anattractive investment proposition for multinational pharmaceutical companies. The public sector willcontinue to fund the majority of healthcare expenditure in Oman. However, the private sector will play apivotal role in healthcare expansion over the long term as compulsory health insurance schemes gaintraction and the government looks to shift some of the financial burden. The rising cost of medical serviceswill be kept in check to an extent by the downward pressure on drug prices - mainly driven by the GCC'smedicine price unification process. Over the long term, Oman's population will benefit from moreaffordable healthcare services as price unification becomes more standardised across the Gulf States.

Headline Expenditure Projections

Pharmaceuticals: OMR242mn (USD629mn) in 2015 to OMR258mn (USD671mn) in 2016; 6.8% inlocal currency and US dollar terms. Forecast in line with Q116.

Healthcare: OMR942mn (USD2.45bn) in 2015 to OMR1.01bn (USD2.60bn) in 2016; +6.3% in localcurrency and US dollar terms. Forecast in line with Q116.


BMI Industry View
Table: Headline Pharmaceuticals & Healthcare Forecasts (Oman 2014-2020)
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Oman 2012-2020)
Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Oman 2012-2020)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Oman 2012-2020)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Oman 2012-2020)
Prescription Drug Market Forecast
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Oman 2012-2020)
Patented Drug Market Forecast
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Oman 2012-2020)
Generic Drug Market Forecast
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Oman 2012-2020)
OTC Medicine Market Forecast
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Oman 2012-2020)
Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade Data And Forecasts (Oman 2014-2020)
Table: Pharmaceutical Trade Data And Forecasts local currency (Oman 2014-2020)
Industry Risk/Reward Index
Middle East and Africa Risk/Reward Index - Q2 2016
Oman Risk/Reward Index
Rewards
Risks
Regulatory Review
Intellectual Property Issues
Pricing Regime
Reimbursement Regime
Market Overview
Healthcare Sector
Table: Healthcare Resources (Oman 2010-2015)
Table: Healthcare Personnel (Oman 2010-2015)
Table: Healthcare Activity (Oman 2010-2015)
Research & Development
Clinical Trials
Epidemiology
Competitive Landscape
Research-Based Industry
Table: Multinational Market Activity
Generic Drugmakers
Pharmaceutical Distribution
Pharmaceutical Retail Sector
Company Profile
National Pharmaceutical Industries
Zynova/Oman Pharmaceutical Products Company
Demographic Forecast
Table: Population Headline Indicators (Oman 1990-2025)
Table: Key Population Ratios (Oman 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Oman 1990-2025)
Table: Population By Age Group (Oman 1990-2025)
Table: Population By Age Group % (Oman 1990-2025)
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Index Methodology
Index Overview
Table: Pharmaceutical Risk/Reward Index Indicators
Indicator Weightings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report